Microbiome & Cancer

The human microbiome has been implicated in altering cancer susceptibility and therapeutic responses to anti-cancer agents. Here is the latest research on the influence of the microbiome and cancer.

October 23, 2019
Preprint
Open Access

A framework for effective application of machine learning to microbiome-based classification problems

bioRxiv
Begum D TopcuogluPatrick D. Schloss
May 26, 2020
Review
Open Access

Gut Microbiota and Pancreatobiliary System

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Ki-Hyun Ryu
February 11, 2020
Review

Human microbiome is a diagnostic biomarker in hepatocellular carcinoma

Hepatobiliary & Pancreatic Diseases International : HBPD INT
Ben-Chen RaoZhi-Gang Ren
October 15, 2019

The Mid-Atlantic Twin Registry of Virginia Commonwealth University

Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies
Emily C H LilleyJudy L Silberg
October 9, 2019
Comment / Editorial
Open Access

Death and the Miser: microbiota regulate the outcome of checkpoint inhibition immunotherapy

Expert Review of Anticancer Therapy
Ger T RijkersFrans J van Overveld
February 5, 2020
Open Access

The Oral Microbiota May Have Influence on Oral Cancer

Frontiers in Cellular and Infection Microbiology
Ling ZhangChen Ping Zhang
February 21, 2020
Review
Open Access

Role of Mycoplasma Chaperone DnaK in Cellular Transformation

International Journal of Molecular Sciences
Francesca BenedettiDavide Zella
November 13, 2019
Review

Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer

Advances in Experimental Medicine and Biology
H Astudillo-de la VegaE Ruiz-Garcia
January 7, 2020
Review

MASS SPECTROMETRY-BASED PERSONALIZED DRUG THERAPY

Mass Spectrometry Reviews
Jia-Jia CuiJi-Ye Yin
June 2, 2020

Microbiome and host crosstalk: A new paradigm to cancer therapy

Seminars in Cancer Biology
Ashutosh SinghNeha Garg
December 28, 2019

The Relationship between Gut Microbiome, Immune System, and Cancer

Gan to kagaku ryoho. Cancer & chemotherapy
Masataka IchikawaTakanori Kanai
October 22, 2019
Review

Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy

Critical Reviews in Oncology/hematology
Stefania GoriGuido Arcaro
February 11, 2020
Review
Open Access

Microbiome and Gastric Cancer

Digestive Diseases and Sciences
Lars Engstrand, David Y Graham
March 6, 2020
Review

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Microbiology and Molecular Biology Reviews : MMBR
Matteo BelloneSamuel Huber
October 22, 2019
Review
Open Access

Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy

EBioMedicine
Ana Montalban-Arques, Michael Scharl

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

© 2020 Meta ULC. All rights reserved
/feed-previews/microbiome-cancer/59424d0e-a1a3-4a78-9321-491fd83fdbd2